Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Harvard and Crucell receive NIH grant for next-generation AdVac vaccines for HIV/AIDS

Aug. 3, 2005

Phase I study of Progenics' novel HIV entry inhibitor completes enrollment

Aug. 1, 2005

European CHMP hands down positive opinion for tipranavir

July 29, 2005

Novel anti-HIV agents reported by Panacos

July 28, 2005

ONO-4128 begins phase III trials in treatment-experienced HIV patients

July 27, 2005

HIV protease inhibitor 640385 receives fast track designation

July 22, 2005

United Biomedical awarded NIH contract for therapeutic AIDS vaccine

July 15, 2005

HIV replication inhibitors from Janssen

July 14, 2005

rIL-7 studied in HIV in two new phase I studies

July 14, 2005

TH-9507 begins phase III trial for HIV-associated lipodystrophy

July 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...